Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia

Relapsed/refractory (rel/ref) acute myeloid leukemia (AML) has a very high mortality rate. At present, hematopoietic stem cell transplantation (HSCT) is the most effective treatment for rel/ref AML. The remission of the primary disease before HSCT is crucial for the transplantation to be effective....

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Wenxiu, Chen, Tianping, Wang, Shen, Li, Chun, Zhang, Bo, Wang, Liang, Xv, Fang, Cao, Fang, Wang, Jing, Chen, Li, Liao, Chenglin, Li, Na, Liu, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982438/
https://www.ncbi.nlm.nih.gov/pubmed/36873635
http://dx.doi.org/10.3389/fped.2023.1117988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982438/
https://www.ncbi.nlm.nih.gov/pubmed/36873635
http://dx.doi.org/10.3389/fped.2023.1117988

Ejemplares similares